Hi Westhot, see sections on Drug development costs and Margins.
Happy to hear feedback if some feel any of the numbers in the model are wrong or I've left out something important. I find it hard to believe myself the results the modelling spits out. Perhaps there's some basic assumptions I'm missing that might explain why the numbers I get are so so much higher than the current share price and analysts targets. I'm certainly not a professional valuer, just an enthusiastic amateur.
Pipeline-in-a-drug, page-31
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.80 |
Change
-0.830(5.31%) |
Mkt cap ! $1.891B | |||
| Open | High | Low | Value | Volume |
| $15.65 | $15.72 | $14.76 | $11.61M | 772.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1392 | $14.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.90 | 1553 | 2 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |